South Korea · Delayed Price · Currency is KRW OceansBio co.,ltd. Statistics
Total Valuation
XKON:332190 has a market cap or net worth of KRW 7.39 billion.
| Market Cap | 7.39B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
XKON:332190 has 1.48 million shares outstanding.
| Current Share Class | 1.48M |
| Shares Outstanding | 1.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 85.77% |
| Owned by Institutions (%) | 7.84% |
| Float | 67,479 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.81 |
| PB Ratio | -21.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.16 |
| Interest Coverage | -36.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -111.96% |
| Return on Invested Capital (ROIC) | -134.23% |
| Return on Capital Employed (ROCE) | 30,463.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5,021.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.45 |
| Average Volume (20 Days) | 41 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XKON:332190 had revenue of KRW 125.65 million and -1.01 billion in losses. Loss per share was -686.00.
| Revenue | 125.65M |
| Gross Profit | 89.11M |
| Operating Income | -1.86B |
| Pretax Income | -1.01B |
| Net Income | -1.01B |
| EBITDA | -1.77B |
| EBIT | -1.86B |
| Loss Per Share | -686.00 |
Balance Sheet
The company has 489.18 million in cash and 960.00 million in debt, giving a net cash position of -470.82 million or -318.59 per share.
| Cash & Cash Equivalents | 489.18M |
| Total Debt | 960.00M |
| Net Cash | -470.82M |
| Net Cash Per Share | -318.59 |
| Equity (Book Value) | -349.90M |
| Book Value Per Share | -258.80 |
| Working Capital | -266.20M |
Cash Flow
In the last 12 months, operating cash flow was -809.35 million and capital expenditures -20.03 million, giving a free cash flow of -829.39 million.
| Operating Cash Flow | -809.35M |
| Capital Expenditures | -20.03M |
| Free Cash Flow | -829.39M |
| FCF Per Share | -561.21 |
Margins
| Gross Margin | 70.92% |
| Operating Margin | -1,482.09% |
| Pretax Margin | -806.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XKON:332190 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.72% |
| FCF Yield | -11.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XKON:332190 has an Altman Z-Score of -10.77 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.77 |
| Piotroski F-Score | 1 |